Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
lipoprotein(a) | 0.444 | 0.769 | 6.6E-89 |
|
group | 0.500 | None | 1.000 | 1 | 1 | 1989 | 2019 | ||||||||
|
coagulation factor V | 0.441 | 0.846 | 5.9E-15 |
|
group | 0.500 | None | 0.971 | 1 | 1 | 1995 | 2016 | ||||||||
|
coagulation factor II, thrombin | 0.415 | 0.885 | 1.1E-03 |
|
group | 0.500 | None | 0.946 | 1 | 1 | 1995 | 2020 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
group | 0.400 | None | 0.933 | 1 | 1 | 1998 | 2019 | ||||||||
|
protein C receptor | 0.560 | 0.692 | 5.6E-03 |
|
group | 0.130 | None | 1.000 | 1 | 1 | 2003 | 2018 | ||||||||
|
collagen type IV alpha 1 chain | 0.484 | 0.731 | 1.00 |
|
group | 0.500 | strong | 1.000 | 2 | 1 | 2006 | 2020 | ||||||||
|
inositol monophosphatase 2 | 0.695 | 0.385 | 1.1E-03 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2007 | 2007 | ||||||||
|
lipase C, hepatic type | 0.585 | 0.654 | 3.3E-07 |
|
group | 0.110 | None | 1.000 | 1 | 1 | 2008 | 2016 | ||||||||
|
CDKN2B antisense RNA 1 | 0.491 | 0.769 |
|
group | 0.160 | None | 1.000 | 3 | 3 | 2009 | 2019 | |||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
group | 0.430 | None | 1.000 | 1 | 1 | 2009 | 2018 | |||||||||
|
HtrA serine peptidase 1 | 0.532 | 0.692 | 4.9E-04 |
|
group | 0.110 | None | 1.000 | 1 | 1 | 2011 | 2018 | ||||||||
|
aldehyde dehydrogenase 2 family member | 0.457 | 0.885 | 3.4E-10 |
|
group | 0.160 | None | 0.857 | 1 | 1 | 2011 | 2019 | ||||||||
|
transcription factor 7 like 2 | 0.485 | 0.846 | 1.00 |
|
group | 0.130 | None | 1.000 | 1 | 1 | 2011 | 2016 | ||||||||
|
zinc finger homeobox 3 | 0.621 | 0.654 | 0.45 |
|
group | 0.480 | None | 1.000 | 3 | 3 | 2012 | 2019 | ||||||||
|
splA/ryanodine receptor domain and SOCS box containing 4 | 0.890 | 0.115 | 4.2E-04 |
|
group | 0.100 | None | 1.000 | 2 | 1 | 2012 | 2014 | ||||||||
|
histone deacetylase 9 | 0.439 | 0.846 | 1.00 |
|
group | 0.500 | None | 1.000 | 2 | 2 | 2012 | 2019 | ||||||||
|
ankyrin repeat and SOCS box containing 3 | 0.861 | 0.192 | 1.4E-07 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
SH2B adaptor protein 3 | 0.527 | 0.692 | 1.0E-04 |
|
group | 0.410 | None | 1.000 | 1 | 1 | 2012 | 2018 | ||||||||
|
tripartite motif containing 29 | 0.606 | 0.654 | 8.1E-08 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | 0.450 | 0.885 | 1.00 |
|
group | 0.110 | None | 1.000 | 2 | 2 | 2014 | 2018 | ||||||||
|
phosphatase and actin regulator 1 | 0.663 | 0.423 | 0.64 |
|
group | 0.110 | None | 1.000 | 1 | 1 | 2014 | 2018 | ||||||||
|
transcription factor 21 | 0.537 | 0.692 | 0.83 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | ||||||||
|
Parkinsonism associated deglycase | 0.535 | 0.808 | 0.75 |
|
group | 0.110 | None | 1.000 | 1 | 1 | 2014 | 2018 | ||||||||
|
phospholipid phosphatase 3 | 0.722 | 0.192 | 0.92 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | ||||||||
|
WD repeat domain 12 | 0.769 | 0.192 | 3.3E-04 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 |